Phase 3 Study of T-DXd and Rilvegostomig Versus SoC in Advanced HER2-expressing Biliary Tract Cancer

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(266 sites)

United States

Research Site, Scottsdale, Arizona

Research Site, Tucson, Arizona

Research Site, Fullerton, California

Research Site, La Jolla, California